Star Excursion Balance for Patellofemoral Pain Syndrome (SEBT)

Effect of Star Excursion Balance Test on Balance, Quality of Life and Functional Status in Patients With Patellofemoral Pain Syndrome

Patellofemoral pain syndrome (PFPS) is a common and painful musculoskeletal condition that affects physically active young adults and causes pain front of the knee. Patients with PFPS has bilateral impairment in proprioception, as well as more in the affected knee than the normal; also the decrease of muscular strength, range of motion, and neuromuscular control are known to result with impaired static and dynamic balance.This study aimed to investigate the efficacy of a-four week YDT balance exercises on pain, quality of life and functional state in patients with PFPS with impaired balance.

Study Overview

• Status: Unknown
• Conditions: Patellofemoral Pain Syndrome
• Intervention / Treatment: Other: Star excursion balance test; Other: Kinesthetic Ability Trainer 2000; Other: SEBT and KAT 2000

Detailed Description

Patellofemoral pain syndrome (PFPS) is a common and painful musculoskeletal condition that affects physically active young adults and causes pain front of the knee. Patients with PFPS has bilateral impairment in proprioception, as well as more in the affected knee than the normal; also the decrease of muscular strength, range of motion, and neuromuscular control are known to result with impaired static and dynamic balance. We aimed to investigate the efficacy of a-four week YDT balance exercises on pain, quality of life and functional state in patients with PFPS with impaired balance.

Patients with PFPS diagnosed will included in the study. Participants will randomized into the YDT exercise group (n = 24), the KAT 2000 exercise group (n = 24) and the combined exercise group (n = 24). Before the study, all groups of patients will given exercises such as quadriceps, vastus medialis oblique (VMO), hip abductor, extensor and external rotator strengthening exercises. All patient groups received balance training for four weeks, three days a week.

Pain intensity will be measure on Visual Analog Scale (VAS). Functional capacity will be evaluated by using the Western Ontario McMaster Osteoarthritis Index (WOMAC) and Kujala Patellofemoral Score (KPS). Static balance performance will be evaluated by using Kinesthetic Ability Trainer 2000 (KAT 2000) and dynamic balance performance will be evaluated by using Berg Balance Scale (BBS) and KAT 2000. The quality of life will assessed using Nottingham Health Profile (NHP).

• Study Type: Interventional
• Enrollment (Anticipated): 72
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Duygu Kerim; Phone Number: 00903122044355; Email: duyguucar231@hotmail.com

Study Locations

• Turkey
  • Ankara, Turkey
    • Recruiting
    • Ufuk University
    • Contact: Duygu Kerim; Email: duyguucar231@hotmail.com
    • Contact: Email: aslihanseyrek@gmail.com
    • Sub-Investigator: ASLIHAN UZUNKULAOGLU
    • Sub-Investigator: SAİME AY

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 20 years to 50 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Between 20 -50 years
• Retropatellar pain
• Positive Clark test, J finding, increased Q angle, positive patellar compression and comphrension test
• Mild or moderate Berg Balance Scale Scores
• body mass index <30
• Mini mental state test score >24

Exclusion Criteria:

• Effusion on patellefemoral site
• Severe neurologic disease
• Trauma history
• Lower extremity surgery history
• Lower extremity fracture history
• severe vitamin B12 deficiency
• another disease led to balance deficit

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: SEBT exercise group; Star Excursion Balance Test will be used	Other: Star excursion balance test; Star excursion balance test,
Active Comparator: KAT 2000 exercise group; Kinesthetic ability trainer will be used	Other: Kinesthetic Ability Trainer 2000; Kinesthetic Ability Trainer 2000
Active Comparator: combined exercise group; Both star Excursion Balance Test exercise and Kinesthetic ability trainer will be used.	Other: SEBT and KAT 2000; Star excursion balance test and Kinesthetic Ability Trainer 2000

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Berg Balance Scale	Berg Balance Scale	1 month

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
patient's global assessment	patient's global assessment	1 month
doctor's global assessment	doctor's global assessment	1 month
Western Ontario McMaster Osteoarthritis Index		1 months
Kujala Patellofemoral Score	Kujala Patellofemoral Score	1 month
Nottingham Health Profile	Nottingham Health Profile	1 month

Collaborators and Investigators

• Sponsor: Ufuk University
• Investigators: Study Chair: ASLIHAN UZUNKULAOGLU, Ufuk University; Study Chair: Saime AY, Ufuk University

Study record dates

Study Major Dates

• Study Start (Actual): January 12, 2018
• Primary Completion (Anticipated): March 1, 2018
• Study Completion (Anticipated): March 1, 2018

Study Registration Dates

• First Submitted: October 24, 2017
• First Submitted That Met QC Criteria: December 6, 2017
• First Posted (Actual): December 7, 2017

Study Record Updates

• Last Update Posted (Actual): January 17, 2018
• Last Update Submitted That Met QC Criteria: January 15, 2018
• Last Verified: January 1, 2018

More Information

Terms related to this study

• Keywords: Balance; Patellofemoral pain syndrome; Star excursion balance test; Kinesthetic Ability Trainer 2000
• Additional Relevant MeSH Terms: Mental Disorders; Pathologic Processes; Disease; Joint Diseases; Musculoskeletal Diseases; Syndrome; Somatoform Disorders; Patellofemoral Pain Syndrome
• Other Study ID Numbers: 26022016-5

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No